By Staff
Wednesday, January 22, 2020 12:21 AM
SAN RAMON, Calif.—CooperVision has named Jane Agbontaen as senior brand director for myopia management–Americas, according to an announcement this week. In this newly created role, Agbontaen will be responsible for the strategic planning and execution of all activities that support the U.S. growth of CooperVision’s myopia management portfolio—specifically the Brilliant Futures Myopia Management Program with MiSight 1 day, the first and only FDA-approved product clinically proven to slow the progression of myopia when initially prescribed for children 8-12 years old in the U.S.
By Staff
Thursday, January 16, 2020 12:21 AM
SAN RAMON, Calif.—
CooperVision, which is preparing for the March 2020 U.S. launch of
MiSight 1 day contact lenses, has kicked off the new year by announcing this week the details of its comprehensive myopia management approach. An initial group of eyecare professionals (ECPs) gathered in Miami on Jan. 7-8 to learn about the “Brilliant Futures Myopia Management Program” and to prepare to prescribe the MiSight 1 day lens to patients. CooperVision’s MiSight 1 day lens is the first and only product approved by the Food and Drug Administration for slowing the progression of myopia when initially prescribed for children 8-12 years old, as
VMAIL reported.
By Staff
Monday, July 15, 2019 12:24 AM
ROCHESTER, N.Y.—
Clerio Vision, a developer of laser-based vision correction solutions, has acquired
Hydrogel Vision Corporation (HVC). Financial details of the transaction were not disclosed. The transaction brings together HVC’s long-standing expertise in the manufacturing and distribution of high performance contact lenses with Clerio’s innovative product pipeline, Clerio said in a statement issued today. HVC, founded in 2002, is best known for its Extreme H2O product line and its multiple differentiated offerings that personalize the contact lens wearing experience.
By Staff
Tuesday, July 9, 2019 12:18 AM
PLEASANTON, Calif.—In the midst of various efforts to improve its global sustainability efforts,
CooperVision Inc. earlier this month published a series of four short videos relating to these sustainability programs. The contact lens company noted it believes providing access to the videos, even in their short form, will resonate more meaningfully with eyecare professionals, partners and others around the world. The company’s multiple environmental initiatives are focused on: saving water and conserving energy; reducing, reusing and recycling resources; and empowering people within the company and the communities in which it operates.
By Staff
Tuesday, December 11, 2018 12:21 AM
LAKE ZURICH, Ill.—Services are planned for long-time contact lens and marketing executive, Thomas F. Steiner, 73, who passed away on Dec. 6 after a long illness. Steiner spent 35 years as a visionary marketing executive in the optical industry with Wesley Jessen and CIBA Vision, and later started a business as a marketing consultant. Among his many accomplishments was his involvement in the launch of cosmetic color contact lenses, and the creation of several unique strategic programs for educating optometrists about the business aspects of practice. He was a mentor to many in the industry.
By Staff
Wednesday, November 7, 2018 12:18 AM
MULLICA HILL, N.J—
OcuMedic, Inc., the first developer of therapeutic lens for the delivery of drugs for the global ophthalmic market, announced their
Contact Drug Delivery System, received a patent by the European Patent Offices, according to a release from the company. The patent will cover all intellectual property of the company’s timed-released delivery of drugs directly to the eye through prescription soft-contact lenses. President and CEO of OcuMedic, Inc., Keith D. Ignotz, said, “The European patent extends the company’s intellectual property coverage to the important European market valued at $16.7 billion annually, growing by 5.6 percent CAGR by 2023, according to Allied Market Research.
By Staff
Thursday, September 13, 2018 12:24 AM
FORT WORTH, Texas—The “new”
Alcon that emerges from a planned spin-off from
Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session.
By Staff
Wednesday, July 18, 2018 12:21 AM
NEW BRUNSWICK, N.J.—
Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational growth of 7.9 percent and a positive currency impact of 3.9 percent.
By Staff
Thursday, July 12, 2018 12:24 AM
FORT WORTH, Texas—
Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the
Star-Telegram of Fort Worth earlier this week.
By Staff
Friday, July 6, 2018 12:24 AM
CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27.
By Staff
Wednesday, June 27, 2018 12:18 AM
BRIDGEWATER, N.J.—
Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with
Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience.
By Staff
Wednesday, June 13, 2018 12:18 AM
CARLSBAD, Calif.—
SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the
Brien Holden Vision Institute, the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on the hybrid contact lens platform. With around half of the world’s population predicted to be myopic by 2050, and with the U.S. Baby Boomer generation now fully presbyopic, it is crucial that technological innovation in contact lens design and manufacturing is translated into high performance products to manage these visual deficiencies, the announcement said.
By Staff
Tuesday, June 5, 2018 12:18 AM
CORAL SPRINGS, Fla.—
ABB Optical Group recently hosted its national sales meeting in Orlando with a focus on the growth of the eyecare industry.
By Staff
Monday, June 4, 2018 11:45 AM
CORAL SPRINGS, Fla.—
ABB Optical Group, which supplies optical products and services for the eyecare industry, has agreed to acquire
Glimpse Live, according to an announcement.
By Staff
Monday, May 21, 2018 12:18 AM
NEW YORK—
Simple Contacts, an eyecare telemedicine company, announced $16 million in funding from Waypoint Capital Partners, with participation from returning investors Goodwater Capital, Steven Cohen, executives from Flatiron Health and some ophthalmologists.